Acquired factor V inhibitor: Success of steroids in a patient with primary sclerosing cholangitis, ulcero haemorragic rectocolitis, biological Biermer's disease

Transfus Clin Biol. 2021 May;28(2):191-193. doi: 10.1016/j.tracli.2021.01.004. Epub 2021 Jan 28.

Abstract

We report the case of a 43-years-old Turkish man with acquired deficiency of factor V (FV) diagnosed in a usual screening before a (recto) colonoscopy. In the biologic explorations, activated partial prothrombin time (APTT) was abnormally high and prothrombin time (PT) was low 18IU/dL with no anticoagulant drugs (the PT was normal 6 months ago). The controlled level of factor V was 3IU/dL with FV antibodies (9 Bethesda Units/mL). This patient had a previous history of primary sclerosing cholangitis (2000) and ulcero haemorrhagic rectocolitis (2002) and a fortuitous biological Biermer's disease was revealed. Corticosteroids were prescribed at 1mg/kg/day with decreasing during 6 months, patient had gradual regression of the caused bleeding and FV became greater than 90%, F V antibodies decreased to less than 0.7 Bethesda Units/mL. This case illustrates the presence of FV inhibitor in an autoimmune gastrointestinal context with regression of clinical (caused) signs and antibodies with corticosteroids.

Keywords: Biological Biermer's disease; F V inhibitor; Primary sclerosing cholangitis; Ulcero haemorrhagic rectocolitis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Coagulation Tests
  • Cholangitis, Sclerosing* / complications
  • Cholangitis, Sclerosing* / drug therapy
  • Factor V
  • Humans
  • Male
  • Proctocolitis*
  • Steroids

Substances

  • Steroids
  • Factor V